Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | BROS Dutch Bros Inc. | 13G | 6% | Mar 31, 2026 | 6mo |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | RDAC Rising Dragon Acquisition Corp. | 13G/A | 8.31% | Mar 31, 2026 | 6mo |
| Caledonia (Private) Investments Pty Ltd | ZG Zillow Group, Inc. | 13G/A | 26.8% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | IMPP Imperial Petroleum Inc./Marshall Islands | 13G/A | 7.8% | Mar 31, 2026 | 6mo |
| LAZARD ASSET MANAGEMENT LLC | TWN Taiwan Fund Inc | 13G | 16.3% | Mar 31, 2026 | 6mo |
| Cormorant Asset Management, LP | AGMB AgomAb Therapeutics NV | 13G | 5.01% | Mar 31, 2026 | 6mo |
| 1607 Capital Partners, LLC | JOF Japan Smaller Capitalization Fund Inc | 13G/A | 12.65% | Mar 31, 2026 | 6mo |
| Saba Capital Management, L.P. | TASK TaskUs, Inc. | 13G/A | 5.72% | Mar 31, 2026 | 6mo |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | MQY Blackrock Muniyield Quality Fund, Inc. | 13G | 5.25% | Mar 31, 2026 | 6mo |
| Discerene Group LP | SABR Sabre Corp | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | CLDI Calidi Biotherapeutics, Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| Oasis Management Co Ltd. | MTN Vail Resorts Inc | 13G/A | 7.9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | MGNX Macrogenics Inc | 13G/A | 9.46% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | IPSC Century Therapeutics, Inc. | 13G/A | 3.3% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | NSPR InspireMD, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| BIOTECHNOLOGY VALUE FUND L P | IMA ImageneBio, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | HBAN Huntington Bancshares Inc | 13G | 6.4% | Mar 31, 2026 | 6mo |
| Bay Pond Partners, L.P. | FSUN Firstsun Capital Bancorp | 13G/A | 4.4% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | HCWB HCW Biologics Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | SABS SAB Biotherapeutics, Inc. | 13G/A | 8.4% | Mar 31, 2026 | 6mo |
| ORBIMED ADVISORS LLC | FBRX Forte Biosciences, Inc. | 13G/A | 4.3% | Mar 31, 2026 | 6mo |
| Alger Associates, Inc. 13-3017981 | FBRX Forte Biosciences, Inc. | 13G/A | 10.2% | Mar 31, 2026 | 6mo |
| ADAR1 Capital Management, LLC | IKT Inhibikase Therapeutics, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| First Light Asset Management, LLC | TLSI TriSalus Life Sciences, Inc. | 13G | 8.75% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | RXO RXO, Inc. | 13G/A | 21.1% | Mar 31, 2026 | 6mo |
| BAKER BROS. ADVISORS LP | GRAL GRAIL, Inc. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| WHITEBOX ADVISORS LLC | ELBM Electra Battery Materials Corp | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| Kynam Capital Management, LP | CLDX Celldex Therapeutics, Inc. | 13G/A | 8.77% | Mar 31, 2026 | 6mo |
| NORWEST VENTURE PARTNERS XIII, LP | TALK Talkspace, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | DCX Digital Currency X Technology Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | LAES SEALSQ Corp | 13G | 5.6% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | NRIX Nurix Therapeutics, Inc. | 13G | 6.3% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | BRCB Black Rock Coffee Bar, Inc. | 13G | 5.5% | Mar 31, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | IVVD Invivyd, Inc. | 13G/A | 7% | Mar 31, 2026 | 6mo |
| Bay Pond Partners, L.P. | RWT Redwood Trust Inc | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| Lingke Wang | LIFE Ethos Technologies Inc. | 13G | 17.5% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | ARTC Art Technology Acquisition Corp. | 13G | 5.7% | Mar 31, 2026 | 6mo |
| Squadron Capital Management LLC | LPCN Lipocine Inc. | 13G/A | 6.2% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | FOXF Fox Factory Holding Corp | 13G/A | 3.55% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | OS OneStream, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| NOMURA HOLDINGS INC | TOON Kartoon Studios, Inc. | 13G | 5.8% | Mar 31, 2026 | 6mo |
| David S. Rosenblatt | DIBS 1stdibs.com, Inc. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | XAIR Beyond Air, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | MBUU Malibu Boats, Inc. | 13G/A | 7.5% | Mar 31, 2026 | 6mo |
| Apollo Management Holdings GP, LLC | CYH Community Health Systems Inc | 13G/A | 8.2% | Mar 31, 2026 | 6mo |
| Driehaus Capital Management LLC | CRNX Crinetics Pharmaceuticals, Inc. | 13G/A | 6.11% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | YCY AA Mission Acquisition Corp. II | 13G/A | 6.59% | Mar 31, 2026 | 6mo |
| Bay Pond Partners, L.P. | ISTR Investar Holding Corp | 13G/A | 3.8% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | KURA Kura Oncology, Inc. | 13G/A | 4.23% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | TDW Tidewater Inc | 13G/A | 6.5% | Mar 31, 2026 | 6mo |